Gotham Asset Management, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$208,381
-27.4%
4,531
-9.2%
0.00%
-33.3%
Q2 2023$286,833
-10.0%
4,991
-41.3%
0.01%
-25.0%
Q1 2023$318,638
-43.9%
8,497
-58.1%
0.01%
-50.0%
Q4 2022$567,741
-12.3%
20,262
-12.0%
0.02%
-15.8%
Q3 2022$647,000
-52.8%
23,032
-41.6%
0.02%
-56.8%
Q2 2022$1,372,000
+249.1%
39,432
+260.4%
0.04%
+266.7%
Q1 2022$393,000
-20.1%
10,940
-57.8%
0.01%
+100.0%
Q3 2016$492,000
+55.7%
25,915
+32.4%
0.01%
+50.0%
Q2 2016$316,00019,5790.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders